Literature DB >> 34241687

The influence of obesity on incidence of complications in patients hospitalized with ovarian hyperstimulation syndrome.

Rachel S Mandelbaum1,2, Liat Bainvoll3, Caroline J Violette1,2, Meghan B Smith2, Shinya Matsuzaki1, Maximilian Klar4, Jacqueline R Ho2, Kristin A Bendikson2, Richard J Paulson2, Koji Matsuo5,6.   

Abstract

OBJECTIVE: To study the impact of body habitus on risk of complications resulting from ovarian hyperstimulation syndrome (OHSS) in hospitalized patients.
METHODS: This is a retrospective observational study examining the National Inpatient Sample between January 2012 and September 2015. Patients were women < 50 years of age diagnosed with OHSS, classified as non-obese, class I-II obesity, or class III obesity. Intervention included multinomial logistic regression to identify factors associated with obesity and binary logistic regression for independent risk factors for complications. Main outcome measures were incidence of (i) any or (ii) multiple complication(s).
RESULTS: Of 2745 women hospitalized with OHSS, 2440 (88.9%) were non-obese, 155 (5.6%) had class I-II obesity, and 150 (5.5%) had class III obesity. Obese women (either class I-II or III) had a higher degree of comorbidity, had lower incomes, and were less likely to have private insurance than non-obese women (all P < 0.001). Obese women had lower rates of OHSS-related complications than non-obese women (any complication: non-obese 65.2%, class I-II 54.8%, and class III 46.7%, P < 0.001; and multiple complications: non-obese 38.5%, class I-II 32.3%, and class III 20.0%, P < 0.001). In the multivariable model, obesity remained independently associated with a decreased risk of complications (class I-II odds ratio 0.57, 95% confidence interval 0.39-0.83, P = 0.003; class III odds ratio 0.30, 95% confidence interval 0.20-0.44, P < 0.001). Obese women were also less likely to require paracentesis (non-obese 32.8%, class I-II 9.7%, and class III 13.3%, P < 0.001).
CONCLUSION: Our study suggests that obesity is associated with decreased OHSS-related complication rates in hospitalized patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Body habitus; Complications; Obesity; Ovarian hyperstimulation syndrome

Mesh:

Year:  2021        PMID: 34241687     DOI: 10.1007/s00404-021-06124-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  37 in total

1.  Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.

Authors:  Tsung-Hsien Lee; Chung-Hsien Liu; Chuin-Chia Huang; Yi-Ling Wu; Yang-Tse Shih; Hong-Nerng Ho; Yu-Shih Yang; Maw-Shang Lee
Journal:  Hum Reprod       Date:  2007-11-13       Impact factor: 6.918

2.  Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation.

Authors:  B Danninger; M Brunner; A Obruca; W Feichtinger
Journal:  Hum Reprod       Date:  1996-08       Impact factor: 6.918

Review 3.  Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

Authors:  D Navot; P A Bergh; N Laufer
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

4.  Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.

Authors:  Barbara Luke; Morton B Brown; Dean E Morbeck; Susan B Hudson; Charles C Coddington; Judy E Stern
Journal:  Fertil Steril       Date:  2009-07-09       Impact factor: 7.329

Review 5.  Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care.

Authors:  A M H Koning; W K H Kuchenbecker; H Groen; A Hoek; J A Land; K S Khan; B W J Mol
Journal:  Hum Reprod Update       Date:  2010-01-07       Impact factor: 15.610

Review 6.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

7.  Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization.

Authors:  Pornanong Aramwit; Kamthorn Pruksananonda; Narat Kasettratat; Karnphat Jammeechai
Journal:  Am J Health Syst Pharm       Date:  2008-06-15       Impact factor: 2.637

8.  Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome.

Authors:  M P Goldsman; A Pedram; C E Dominguez; I Ciuffardi; E Levin; R H Asch
Journal:  Fertil Steril       Date:  1995-02       Impact factor: 7.329

Review 9.  Effect of overweight and obesity on assisted reproductive technology--a systematic review.

Authors:  A Maheshwari; Lawrize Stofberg; S Bhattacharya
Journal:  Hum Reprod Update       Date:  2007-06-21       Impact factor: 15.610

Review 10.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

View more
  2 in total

1.  Female obesity and infertility: outcomes and regulatory guidance.

Authors:  Susanna Marinelli; Gabriele Napoletano; Marco Straccamore; Giuseppe Basile
Journal:  Acta Biomed       Date:  2022-08-31

Review 2.  Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Authors:  Jing Li; Hongli Duan; Yan Liu; Lu Wang; Xing Zhou
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.